A decision framework to evaluate intellectual property strategies in the medical nutrition market

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +14

Protecting Their Intellectual Assets: Appropriability Conditions and Why U.S. Manufacturing Firms Patent (or Not)

Wesley M. Cohen, Richard R. Nelson, John P. Walsh · National Bureau of Economic Research · 2000 · 1.9K citations · Full text

Management, Innovation Management, Strategy +15

The relative effectiveness of patents and secrecy for appropriation

Anthony Arundel · Research Policy · 2001 · 852 citations

Law, Intellectual Property Law, Technology Management +12

R&D spillovers, patents and the incentives to innovate in Japan and the United States

Wesley M. Cohen, Akira Gotō, Akiya Nagata et al. · Research Policy · 2002 · 713 citations

Management, Economics, Innovation Management +14

Motives to patent: Empirical evidence from Germany

Knut Blind, Jakob Edler, Rainer Frietsch et al. · Research Policy · 2006 · 617 citations

Management, Innovation Management, Intellectual Property Law +12